SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-011318
Filing Date
2024-04-22
Accepted
2024-04-22 16:34:11
Documents
2
Period of Report
2024-04-18

Document Format Files

Seq Description Document Type Size
1 form3-04222024_080459.html 3  
1 form3-04222024_080459.xml 3 1759
2 ex24-04222024_080459.htm EX-24 5729
  Complete submission text file 0001415889-24-011318.txt   9257
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHEMOCENTRYX, INC. 850 MAUDE AVE. MOUNTAIN VIEW CA 94043
Business Address
Fairey William (Reporting) CIK: 0001727275 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36830 | Film No.: 24861613